×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
戻る Agenda
Session 5 Track B: What's Really Needed to Transform Information Flow in Clinical Development
Session Chair(s)
Prem Sreenivasan, PhD
Director
HITLAB, United States
Sound familiar?
- "Automation, AI, and digitization are buzz words – my team is stuck with manual processes and too many systems to use."
- "The technology exists; organizations aren’t ready to use it."
- "We have to customize data standards to use them, and there are still too many gaps." We need to approach transformation of clinical information flow from multiple angles. This session will discuss how three different TransCelerate initiatives can be used to guide industry toward a future in which digital data flows seamlessly across the various systems and software used in clinical development.
Learning Objective : - Summarize an open, vendor-agnostic, digital flow of data relevant to improving and optimizing study designs
- Understand the study design data available to other systems that can utilize this data in order to configure and execute a study design
- Articulate use cases in registry/disclosure and other valuable information extractions from protocol, SAP and CSR
- Identify approaches utilized to improve data flow in clinical trials
Speaker(s)
From Point Solution to Data Exchanged Across Platforms - TransCelerate’s Digital Data Flow Initiative
Alison Luckman
Amgen Ltd, United Kingdom
Development Operations Innovation Director
From Documents to Content As Data: TransCelerate’s Clinical Content & Reuse Initiative
Tatiana Gabriella Piotroff, MS
Johnson and Johnson, United States
Senior Manager, Medical Writing
From Transcription to Interoperability: TransCelerate’s eSource Initiative
Mehek Mohan
Genentech, Inc., United States
Product Manager for Technology Development and Artificial Intelligence